
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Integrin α3/ITGA3/CD49c CRISPR/Cas9 KO Plasmid (m2) | sc-421161-KO-2 | 20 µg | $397.00 |
Itga3 encodes integrin α3 (ITGA3/CD49c), an α subunit that pairs with β1 to form the laminin-binding α3β1 integrin, a key mediator of cell–extracellular matrix adhesion. Through focal adhesion signaling, ITGA3 influences cytoskeletal organization and activates downstream pathways such as FAK/Src, PI3K–AKT, and MAPK to regulate migration, survival, and epithelial morphogenesis. In mouse tissues, integrin α3 contributes to basement membrane interactions and epithelial barrier architecture, linking it to processes such as wound-associated remodeling and cell polarity. Altered ITGA3-integrin signaling is frequently studied in contexts of invasive behavior, inflammation-associated tissue remodeling, and organ developmental phenotypes.
Integrin α3/ITGA3/CD49c CRISPR/Cas9 KO Plasmid (m2) is a pool of plasmids designed for targeted disruption of the Itga3 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Itga3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Itga3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Integrin α3/ITGA3/CD49c protein expression.
This CRISPR knockout system enables efficient generation of Itga3-deficient cell models for investigation of Integrin α3/ITGA3/CD49c signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.